| Literature DB >> 30713785 |
Fiamma Salerno1, Aurelie Guislain1, Julian J Freen-Van Heeren1, Benoit P Nicolet1, Howard A Young2, Monika C Wolkers1.
Abstract
Protective T cell responses against tumors require the production of Interferon gamma (IFN-γ). However, tumor-infiltrating T cells (TILs) gradually lose their capacity to produce IFN-γ and therefore fail to clear malignant cells. Dissecting the underlying mechanisms that block cytokine production is thus key for improving T cell products. Here we show that although TILs express substantial levels of Ifng mRNA, post-transcriptional mechanisms impede the production of IFN-γ protein due to loss of mRNA stability. CD28 triggering, but not PD1 blocking antibodies, effectively restores the stability of Ifng mRNA. Intriguingly, TILs devoid of AU-rich elements within the 3'untranslated region maintain stabilized Ifng mRNA and produce more IFN-γ protein than wild-type TILs. This sustained IFN-γ production translates into effective suppression of tumor outgrowth, which is almost exclusively mediated by direct effects on the tumor cells. We therefore conclude that post-transcriptional mechanisms could be modulated to potentiate effective T cell therapies in cancer.Entities:
Keywords: B16 melanoma; CD28; IFN-γ; PD-1; Tumor-infiltrating T cells; mRNA stability; post-transcriptional regulation
Year: 2018 PMID: 30713785 PMCID: PMC6343783 DOI: 10.1080/2162402X.2018.1532762
Source DB: PubMed Journal: Oncoimmunology ISSN: 2162-4011 Impact factor: 8.110